› navigate
Dr. Helmut M. Schühsler

Chairman & Managing Partner (based in Munich and Dubai)

Dr. Helmut M. Schühsler

Chairman & Managing Partner (based in Munich and Dubai)Dr. Helmut M. Schühsler serves as Chairman and Managing Partner of the TVM Life Science Venture Capital Practice with offices in Munich and Montreal and as Chairman and Chief Executive Officer of TVM Capital MENA Ltd., Dubai, UAE.

Since joining TVM Capital in 1990, Dr. Schühsler has been the deal maker on more than 20 direct investments in life science companies in Europe and the U.S. In total he has overseen more than 80 investments in the health market and has built the TVM Capital Life Science practice as an internal start up within the firm to its market position today.

In 2007 and 2008, Dr. Schühsler served as chairman of the European Private Equity and Venture Capital Association (EVCA).

Currently he is chairman of healthcare growth companies, ProVita International Medical Center (Abu Dhabi, UAE) and Bourn Hall International (Dubai, India), Cambridge Medical and Rehabilitation Center (Abu Dhabi, UAE) and Manzil Health Care Services (Abu Dhabi). He also serves as director at SelectX Pharmaceuticals, Inc. (Boston, MA, USA, Concert Pharmaceuticals (Lexingtona, MA, USA), the board of Max-Planck Innovation GmbH. In 2009 – 2012 Dr. Schühsler was a member of the Selection Committee for the Technology Pioneers program, the Steering Committee of the Entrepreneurship and Successful Growth Research Program of the World Economic Forum (2009-2012) and the advisory board of Evolvence India Life Science Fund, Hyderabad, India.